Clinical Trial Update: Adaptive tDCS for Treatment-Resistant MDD [Phase 1]

View source ↗

Summary

A Phase 1 adaptive transcranial direct current stimulation (tDCS) trial for treatment-resistant depression has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Treatment-resistant Depression

Snippet

Sponsor: Washington University School of Medicine | Conditions: Depressive Disorder, Treatment-Resistant | Phase 1 | Status: TERMINATED